Winship Cancer Institute of Emory University ( Site 0037) — Atlanta, Georgia

Public research footprint of Winship Cancer Institute of Emory University ( Site 0037), compiled from the ClinicalTrials.gov public registry.

257

Registered studies

Active

Recruiting now

143

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed B-Cell Non-Hodgkin Lymphoma · Multiple Myeloma · Breast Cancer · Brain Tumor, Adult: Glioblastoma

Recently updated registry entries

NCT06158841 — Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… (Recruiting)
NCT06270706 — A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors (Recruiting)
NCT07265947 — Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Winship Cancer Institute of Emory University ( Site 0037)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.